During the first year of the COVID-19 pandemic, emergency use authorizations (EUAs) from the U.S. Food and Drug Administration of COVID-19-related medical products were for diagnostic products and were supported by comparisons ...
Dec 30, 2021
0
20
Last week, AstraZeneca's chief executive officer said the company's COVID vaccine may provide longer-lasting protection than mRNA vaccines like Pfizer's, especially in older people.
Nov 29, 2021
0
1
The Covax scheme aimed at equitable global access to COVID-19 vaccines has now delivered more than 500 million doses around the world, figures showed Wednesday.
Nov 17, 2021
0
1
Globally affordable COVID-19 vaccines will not be accessible until governments stop allowing vaccine companies to keep their manufacturing costs secret, according to a new paper published by the Journal of the Royal Society ...
Nov 4, 2021
0
1
Swiss pharmaceuticals giant Novartis said Thursday it has signed a new agreement to farm out some of its production facilities and help manufacture much-needed doses of the Pfizer-BioNTech coronavirus vaccine.
Oct 21, 2021
0
6
Franco-Austrian biotech lab Valneva announced Monday positive results from clinical trials of its COVID vaccine candidate, a month after the UK government terminated a supply deal with the company.
Oct 18, 2021
1
40
US pharmaceutical giant Moderna announced Thursday it would build a plant in Africa, as pressure mounts on drugmakers to help ramp up COVID-19 vaccine production in areas that have received fewer doses.
Oct 7, 2021
0
2
COVID-19 vaccine production has scaled up significantly. Global output is now estimated to be over 1.5 billion doses a month, rapidly propelling the world towards the 11.3 billion doses needed to vaccinate 80% of teenagers ...
Oct 5, 2021
0
3
The coronavirus pandemic has made vaccine production a hot topic covered daily in the Danish media. How much can be produced and when can the coveted vials be delivered? The Danish vaccine producer Bavarian Nordic asks itself ...
Sep 27, 2021
0
2
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment—which depletes the B cells that contribute to the MS attacks—are able to mount robust T-cell responses to the mRNA COVID-19 ...
Sep 15, 2021
0
176
